Dynavax Technologies Corporation ( DVAX) - Key Metrics
Stock symbol DVAX is outdated, potentially delisted? Maybe it is available on other exchange?
DVAX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $0.81 | $0.23 | $0.29 | $0.28 |
| 2025Q2 | $0.80 | $0.16 | $0.20 | $0.18 |
| 2025Q1 | $0.55 | -$0.77 | -$0.16 | -$0.19 |
| 2024Q4 | $0.56 | $0.06 | $0.41 | $0.39 |
| 2024Q3 | $0.61 | $0.13 | $0.15 | $0.14 |
DVAX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | ? | 10.81 |
| 2025Q2 | ? | 15.81 |
| 2025Q1 | ? | -4.21 |
| 2024Q4 | ? | 57.94 |
| 2024Q3 | ? | 20.76 |
DVAX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q3 | 2.80% | ? |
| 2025Q2 | 1.86% | ? |
| 2025Q1 | -1.46% | ? |
| 2024Q4 | 3.03% | ? |
| 2024Q3 | 1.24% | ? |
DVAX
Price: $15.50
52 week price:
Earnings Per Share: -0.37 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 1.5 million
Ebitda: -21.6 millionMarket Capitalization: 1.8 billion